These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30219927)

  • 1. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
    Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2018 Nov; 132(6):1645-1657. PubMed ID: 30219927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA.
    Adamowicz P
    Forensic Sci Int; 2016 Apr; 261():e5-10. PubMed ID: 26934903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
    Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
    Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation on the distribution of cannabinoids in man.
    Gronewold A; Skopp G
    Forensic Sci Int; 2011 Jul; 210(1-3):e7-e11. PubMed ID: 21570784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
    Bäckberg M; Tworek L; Beck O; Helander A
    J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine.
    Lehmann S; Sczyslo A; Froch-Cortis J; Rothschild MA; Thevis M; Andresen-Streichert H; Mercer-Chalmers-Bender K
    Forensic Sci Int; 2019 Oct; 303():109959. PubMed ID: 31546164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
    Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
    Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feature-Based Molecular Network for New Psychoactive Substance Identification: The Case of Synthetic Cannabinoids in a Seized e-Liquid and Biological Samples.
    Magny R; Lefrère B; Roulland E; Auzeil N; Farah S; Richeval C; Gish A; Vodovar D; Labat L; Houzé P
    J Am Soc Mass Spectrom; 2024 Oct; 35(10):2276-2287. PubMed ID: 39186500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA.
    Walle N; Doerr AA; Schmidt PH; Schaefer N
    Drug Test Anal; 2023 Mar; 15(3):368-373. PubMed ID: 36415074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
    Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
    Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
    Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
    Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
    Krotulski AJ; Cannaert A; Stove C; Logan BK
    Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
    Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2019 May; 133(3):973. PubMed ID: 30515589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.